Zhuzhou Qianjin Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhuzhou Qianjin Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Jilin Aodong Medicine Industry (Group) Co., Ltd.
sales of 3.32 billion Chinese Renmimbi [US$469.55 million]
of which 95%
was Pharmaceutical Manufacturing),
Guangxi Wuzhou Zhongheng Group, Ltd.
(3.30 billion Chinese Renmimbi [US$465.93 million]
of which 96%
was Pharmaceutical Segment), and
Guangdong Taiantang Pharmaceutical Co Ltd
(3.31 billion Chinese Renmimbi [US$468.01 million]
of which 70%
was Medicine Wholesale & Retail).
During the year ended December of 2018, sales at
Zhuzhou Qianjin Pharmaceutical Co., Ltd. were 3.33 billion Chinese Renmimbi (US$470.15 million).
increase of 4.6%
versus 2017, when the company's sales were 3.18 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Zhuzhou Qianjin Pharmaceutical Co., Ltd.
(and since 2013, sales have increased a total of 69%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
185.4% in 2018, from
257.97 million Chinese Renmimbi to 736.28 million Chinese Renmimbi.
Not all segments of Zhuzhou Qianjin Pharmaceutical Co., Ltd. experienced an increase in sales in 2018:
sales of Medicine Retail Sales and Wholesales fell 34.8% to 886.21 million Chinese Renmimbi.
Zhuzhou Qianjin Pharmaceutical Co., Ltd. also experienced decreases in sales in
Medicine Manufacturing (down 15.0% to 1.44 billion Chinese Renmimbi)